Company intelligence / Profile preview

Precision Scientific

China

Ownership: Private
Development stage: Other

Overview

Precision Scientific delivers CRO services and operates the AIBERT platform for AI-driven multi-omics data mining supporting drug target discovery, biomarker identification, and other aspects of precision oncology research, as well as offering companion diagnostic development and central laboratory services.

Therapeutic areas: Oncology
Modalities: biologicssmall moleculescompanion diagnostics
Industry: Contract Research Organization

Partnerships

biotechnology and pharmaceutical companiesacademic institutionshealthcare institutions

Beyond the preview

Go deeper on Precision Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Precision Scientific.

Explore the full profile